Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2402573.pdf
Reference48 articles.
1. Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N . LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 1989 7: 1018–1026
2. Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE . Treatment of childhood acutelymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute lymphoblastic leukemia Consortium Protocol 85–01 J Clin Oncol 1994 12: 740–747
3. Moser AM, Adamson PC . Intraventricular concentration times time (C × T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma Cancer 1999 85: 511–516
4. Porchedly C . Prevention of meningeal leukemia. Review of 20 years of research and current recommendations Hematol Oncol Clin N Am 1990 4: 951–969
5. Pinkel D, Woo S . Prevention and treatment of meningeal leukemia in children Blood 1994 84: 355–366
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prophylaxis and Treatment of Central Nervous System (CNS) Acute Lymphoblastic Leukemia;Clinical Management of Acute Lymphoblastic Leukemia;2022
2. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives;Cancers;2021-10-12
3. MTX-HOPE is a low-dose salvage chemotherapy for aged patients with relapsed or refractory non-Hodgkin lymphoma;Journal of Clinical and Experimental Hematopathology;2021
4. Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy;British Journal of Haematology;2015-12-18
5. Identification of Combinatorial Drugs that Synergistically Kill both Eribulin-Sensitive and Eribulin-Insensitive Tumor Cells;Global Journal of Cancer Therapy;2015-11-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3